Ernest Leek

Ernest Leek joined Immatics in July 2025 and is responsible for developing commercial analytics capabilities, optimizing go-to-market planning and facilitating data-driven decision-making across all stages of launch readiness.

With over two decades of leadership experience in data, analytics and commercial strategy across the U.S. and European biopharmaceutical industries, Ernest has a proven track record of driving launch excellence and building high-performing teams in oncology, cell therapy and rare diseases. He has led analytics and insights functions at organizations such as Akero Therapeutics, Mirati Therapeutics, Iovance Biotherapeutics, Prothena, InterMune and Amgen.

Ernest Leek holds a master's in business administration from the University of Seattle.